Poor survival linked to Puerto Rican women with triple-negative breast cancer subtype

Share this article:
Puerto Rican women with triple-negative breast cancer subtype have an increased risk of breast cancer death, according to a study presented at the 2010 AACR Conference on The Science of Cancer Health Disparities.

For the study, researchers analyzed data for 974 female patients with invasive breast cancer, among which 16.6% were triple negative, neither overexpressing HER2neu nor receptive to estrogen or progesterone.

The scientists reported that the risk of breast cancer death for Puerto Rican women who had the triple-negative breast cancer subtype was more than twice as high compared to women with other tumor subtypes. In addition, women who were age 50 years or younger at the time of diagnosis and had regional/distant disease were also more likely to die as a result of their breast cancer.

“Findings, which were consistent with results described in previous studies of U.S. populations, will be useful in the development of cancer control strategies in Puerto Rico and may have an impact on future studies of targeted therapies to improve breast cancer survival in other Hispanic populations,” concluded Ana Ortiz Martinez, MPH, PhD, associate professor and researcher at the University of Puerto Rico Cancer Center and the department of biostatistics and epidemiology, Graduate School of Public Health, University of Puerto Rico.

Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Web Exclusives

High-risk leukemia subtype becomes more common with age

Many young adults with the most common form of acute lymphoblastic leukemia (ALL) have a high-risk subtype with a poor prognosis and could benefit from drugs used to treat other types of leukemia.

Better classifications improve treatment planning for breast cancer

Scientists have developed a tool to distinguish each breast cancer subtype, research that could improve treatments and targeting of treatments for the disease.

Tumor cells prep lymphatic cells to encourage breast cancer cells to spread

Breast cancer cells can lay the groundwork for their own metastasis throughout the body by coaxing cells within lymphatic vessels to send out tumor-welcoming signals.